rs35592493

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003114.5(SPAG1):​c.669A>G​(p.Gly223Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0119 in 1,588,374 control chromosomes in the GnomAD database, including 868 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.037 ( 300 hom., cov: 32)
Exomes 𝑓: 0.0093 ( 568 hom. )

Consequence

SPAG1
NM_003114.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.15

Publications

5 publications found
Variant links:
Genes affected
SPAG1 (HGNC:11212): (sperm associated antigen 1) The correlation of anti-sperm antibodies with cases of unexplained infertility implicates a role for these antibodies in blocking fertilization. Improved diagnosis and treatment of immunologic infertility, as well as identification of proteins for targeted contraception, are dependent on the identification and characterization of relevant sperm antigens. The protein expressed by this gene is recognized by anti-sperm agglutinating antibodies from an infertile woman. Furthermore, immunization of female rats with the recombinant human protein reduced fertility. This protein localizes to the plasma membrane of germ cells in the testis and to the post-acrosomal plasma membrane of mature spermatozoa. Recombinant polypeptide binds GTP and exhibits GTPase activity. Thus, this protein may regulate GTP signal transduction pathways involved in spermatogenesis and fertilization. Two transcript variants of this gene encode the same protein. [provided by RefSeq, Jul 2008]
SPAG1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 8-100184701-A-G is Benign according to our data. Variant chr8-100184701-A-G is described in ClinVar as Benign. ClinVar VariationId is 416524.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.15 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPAG1NM_003114.5 linkc.669A>G p.Gly223Gly synonymous_variant Exon 7 of 19 ENST00000388798.7 NP_003105.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPAG1ENST00000388798.7 linkc.669A>G p.Gly223Gly synonymous_variant Exon 7 of 19 1 NM_003114.5 ENSP00000373450.3
SPAG1ENST00000251809.4 linkc.669A>G p.Gly223Gly synonymous_variant Exon 7 of 19 5 ENSP00000251809.3
SPAG1ENST00000520508.5 linkc.669A>G p.Gly223Gly synonymous_variant Exon 7 of 10 5 ENSP00000428070.1
SPAG1ENST00000520643.5 linkc.669A>G p.Gly223Gly synonymous_variant Exon 7 of 10 2 ENSP00000427716.1

Frequencies

GnomAD3 genomes
AF:
0.0369
AC:
5617
AN:
152136
Hom.:
296
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.108
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0166
Gnomad ASJ
AF:
0.00433
Gnomad EAS
AF:
0.100
Gnomad SAS
AF:
0.0470
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00106
Gnomad OTH
AF:
0.0277
GnomAD2 exomes
AF:
0.0206
AC:
4629
AN:
224248
AF XY:
0.0193
show subpopulations
Gnomad AFR exome
AF:
0.101
Gnomad AMR exome
AF:
0.0123
Gnomad ASJ exome
AF:
0.00587
Gnomad EAS exome
AF:
0.0996
Gnomad FIN exome
AF:
0.0000470
Gnomad NFE exome
AF:
0.00108
Gnomad OTH exome
AF:
0.0105
GnomAD4 exome
AF:
0.00926
AC:
13292
AN:
1436120
Hom.:
568
Cov.:
29
AF XY:
0.00977
AC XY:
6975
AN XY:
714264
show subpopulations
African (AFR)
AF:
0.111
AC:
3503
AN:
31586
American (AMR)
AF:
0.0139
AC:
528
AN:
37966
Ashkenazi Jewish (ASJ)
AF:
0.00481
AC:
123
AN:
25580
East Asian (EAS)
AF:
0.112
AC:
4270
AN:
37968
South Asian (SAS)
AF:
0.0391
AC:
3163
AN:
80922
European-Finnish (FIN)
AF:
0.0000564
AC:
3
AN:
53236
Middle Eastern (MID)
AF:
0.00944
AC:
54
AN:
5720
European-Non Finnish (NFE)
AF:
0.000631
AC:
697
AN:
1103802
Other (OTH)
AF:
0.0160
AC:
951
AN:
59340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
561
1121
1682
2242
2803
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0370
AC:
5639
AN:
152254
Hom.:
300
Cov.:
32
AF XY:
0.0373
AC XY:
2781
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.108
AC:
4490
AN:
41508
American (AMR)
AF:
0.0166
AC:
254
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00433
AC:
15
AN:
3468
East Asian (EAS)
AF:
0.0999
AC:
518
AN:
5186
South Asian (SAS)
AF:
0.0468
AC:
226
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00106
AC:
72
AN:
68024
Other (OTH)
AF:
0.0289
AC:
61
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
261
523
784
1046
1307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0153
Hom.:
70
Bravo
AF:
0.0412
Asia WGS
AF:
0.0750
AC:
260
AN:
3470

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 04, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 28 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Jul 08, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
5.8
DANN
Benign
0.68
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35592493; hg19: chr8-101196929; COSMIC: COSV52560161; COSMIC: COSV52560161; API